PECONDLE® (picankibart injection) has received approval from China's National Medical Products Administration (NMPA) for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systematic therapy. PECONDLE® is the world's first IL-23p19 antibody whose...
Hence then, the article about china s first domestic il 23p19 monoclonal antibody innovent s pecondle picankibart injection received nmpa approval was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( China's First Domestic IL-23p19 Monoclonal Antibody: Innovent's PECONDLE® (Picankibart Injection) Received NMPA Approval )
Also on site :
- Frank Lloyd Wright’s Price Tower sold for $10 in 2023; in 2025, a court-approved sale brought in $1.4 million
- Who Won ‘The Challenge: Cutthroat’? Season 42 Winners Revealed
- Tiger Woods founded a junior golf clinic in 1996 with his father Earl for inner-city kids; the foundation has since raised more than $50 million for education